Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
This meta-analysis synthesizes data from 38 studies on CAR T-cell therapy for central nervous system lymphoma. It reports pooled efficacy outcomes, including an overall response rate of 0.75, and safety profiles for Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome. The analysis was conducted by Ahmad E. Shawabkeh and published in 2026.
Data is presented in a DOCX file containing the meta-analysis manuscript, not in a structured data format like CSV; extraction of numerical results is required for computational use. License is CC BY 4.0.